Cholecystokinin Antagonists—A Toxicologic Perspective
- 1 January 1992
- journal article
- review article
- Published by Taylor & Francis in Drug Metabolism Reviews
- Vol. 24 (2) , 267-293
- https://doi.org/10.3109/03602539208996295
Abstract
No abstract availableKeywords
This publication has 90 references indexed in Scilit:
- OmeprazoleDigestive Diseases and Sciences, 1991
- CCK antagonists interact with CCK-B receptors on human small cell lung cancer cellsPeptides, 1990
- The Gastrin HypothesisJournal of Clinical Gastroenterology, 1990
- Role of gastrin and cholecystokinin in tumours of the gastrointestinal tractEuropean Journal of Cancer and Clinical Oncology, 1988
- The Opioids, Dopamine, Cholecystokinin, and Eating DisordersClinical Neuropharmacology, 1986
- Enterochromaffin-Like Cell Carcinoids of Gastric Mucosa in Rats after Life-Long Inhibition of Gastric SecretionDigestion, 1986
- Hypergastrinemia and colorectal carcinogenesis in the ratCancer Letters, 1985
- Benzodiazepines antagonize cholecystokinin-induced activation of rat hippocampal neuronesNature, 1984
- Carcinogenesis bioassay of prazepam (verstran) in rats and miceToxicology and Applied Pharmacology, 1981
- Evidence for coexistence of dopamine and CCK in meso-limbic neuronesNature, 1980